CNN3
gene geneOn this page
Summary
CNN3 (calponin 3, HGNC:2157) is a protein-coding gene on chromosome 1p21.3, encoding Calponin-3 (Q15417). Thin filament-associated protein that is implicated in the regulation and modulation of smooth muscle contraction.
This gene encodes a protein with a markedly acidic C terminus; the basic N-terminus is highly homologous to the N-terminus of a related gene, CNN1. Members of the CNN gene family all contain similar tandemly repeated motifs. This encoded protein is associated with the cytoskeleton but is not involved in contraction.
Source: NCBI Gene 1266 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 33 total — 1 pathogenic
- GTEx eGene: eQTL in 26 tissues, sQTL in 4 (q < 0.05)
- Constraint (gnomAD): pLI 1.00 (loss-of-function intolerant), LOEUF 0.43 (moderately constrained)
- MANE Select transcript:
NM_001839 - Interaction hub: 1,725 STRING partners (top 10% of genes corpus-wide)
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:2157 |
| Approved symbol | CNN3 |
| Name | calponin 3 |
| Location | 1p21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000117519 |
| Ensembl biotype | protein_coding |
| OMIM | 602374 |
| Entrez | 1266 |
Gene structure
Transcript identifiers
Ensembl transcripts: 18 — 12 protein_coding, 3 protein_coding_CDS_not_defined, 3 nonsense_mediated_decay
MANE Select: ENST00000370206
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 2: 5, TSL 3: 1
ENST00000370206, ENST00000394202, ENST00000415017, ENST00000461018, ENST00000474409, ENST00000487539, ENST00000545882, ENST00000885995, ENST00000885996, ENST00000939684, ENST00000939685, ENST00000998672, ENST00001022727, ENST00001022733, ENST00001121661, ENST00001123633, ENST00001123634, ENST00001144648
RefSeq mRNA: 3 — MANE Select: NM_001839
NM_001286055, NM_001286056, NM_001839
CCDS: CCDS30775, CCDS65592, CCDS65593
Canonical transcript exons
ENST00000370206 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001887536 | 94896957 | 94898083 |
| ENSE00001928046 | 94926838 | 94927110 |
| ENSE00003477154 | 94899371 | 94899517 |
| ENSE00003523278 | 94902121 | 94902258 |
| ENSE00003527145 | 94901669 | 94901785 |
| ENSE00003643594 | 94903122 | 94903188 |
| ENSE00003661769 | 94903403 | 94903524 |
Expression profiles
Bgee: expression breadth ubiquitous, 289 present calls, max score 99.68.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 238.6389 / max 1615.8375, expressed in 1474 samples.
Highest expression (Bgee): ventricular zone, calcaneal tendon, ganglionic eminence, adrenal gland, tibial nerve.
Genetic regulation across tissues (GTEx eQTL / sQTL)
CNN3 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 26 tissues and its splicing (sQTL) in 4 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
showing 20 of 30 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Brain Cerebellar Hemisphere | eqtl | 9.6e-30 | +0.71 | 1:94855162:T:C |
| Brain Cerebellum | eqtl | 1.6e-19 | +0.48 | 1:94855162:T:C |
| Nerve Tibial | eqtl | 3.1e-09 | -0.15 | 1:94909143:T:C |
| Esophagus Muscularis | eqtl | 6.7e-09 | -0.20 | 1:94899861:A:G |
| Colon Sigmoid | eqtl | 7.6e-07 | +0.15 | 1:94887366:ATC:A |
| Artery Aorta | eqtl | 2.4e-06 | -0.19 | 1:94919559:C:G |
| Adipose Subcutaneous | eqtl | 7.8e-06 | +0.13 | 1:94892540:A:G |
| Brain Caudate basal ganglia | eqtl | 2.5e-05 | +0.13 | 1:94887607:A:G |
| Colon Transverse | eqtl | 5.6e-05 | -0.12 | 1:94960809:A:G |
| Skin Sun Exposed Lower leg | eqtl | 1.2e-04 | +0.16 | 1:95142839:G:C |
| Artery Coronary | eqtl | 1.6e-04 | -0.26 | 1:94899861:A:G |
| Esophagus Gastroesophageal Junction | eqtl | 1.8e-04 | -0.17 | 1:94899861:A:G |
| Skin Not Sun Exposed Suprapubic | eqtl | 2.4e-04 | +0.09 | 1:94945045:C:A |
| Artery Tibial | eqtl | 2.6e-04 | +0.10 | 1:94887145:T:A |
| Breast Mammary Tissue | eqtl | 4.0e-04 | +0.13 | 1:94906171:C:T |
| Brain Cortex | eqtl | 7.0e-04 | +0.11 | 1:94887607:A:G |
| Brain Nucleus accumbens basal ganglia | eqtl | 8.8e-04 | +0.13 | 1:94887607:A:G |
| Brain Frontal Cortex BA9 | eqtl | 1.0e-03 | +0.11 | 1:94887607:A:G |
| Heart Left Ventricle | eqtl | 1.4e-03 | +0.18 | 1:94932483:G:T |
| Cells Cultured fibroblasts | eqtl | 1.5e-03 | +0.12 | 1:94887650:G:T |
FANTOM5 promoters
5 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 13424 | 221.4853 | 1469 |
| 13423 | 15.8935 | 1343 |
| 13422 | 0.9221 | 347 |
| 13421 | 0.2203 | 87 |
| 13425 | 0.1178 | 28 |
Top tissues by expression
showing 100 of 295 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ventricular zone | UBERON:0003053 | 99.68 | gold quality |
| calcaneal tendon | UBERON:0003701 | 99.50 | gold quality |
| ganglionic eminence | UBERON:0004023 | 99.39 | gold quality |
| left adrenal gland | UBERON:0001234 | 99.28 | gold quality |
| right adrenal gland | UBERON:0001233 | 99.26 | gold quality |
| tibial nerve | UBERON:0001323 | 99.25 | gold quality |
| body of uterus | UBERON:0009853 | 99.23 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 99.22 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 99.19 | gold quality |
| left uterine tube | UBERON:0001303 | 99.12 | gold quality |
| right lung | UBERON:0002167 | 99.07 | gold quality |
| metanephros cortex | UBERON:0010533 | 99.07 | gold quality |
| ectocervix | UBERON:0012249 | 99.03 | gold quality |
| adrenal gland | UBERON:0002369 | 99.01 | gold quality |
| colonic epithelium | UBERON:0000397 | 99.00 | gold quality |
| adrenal tissue | UBERON:0018303 | 99.00 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 98.98 | gold quality |
| gall bladder | UBERON:0002110 | 98.94 | gold quality |
| right coronary artery | UBERON:0001625 | 98.93 | gold quality |
| left ovary | UBERON:0002119 | 98.93 | gold quality |
| left coronary artery | UBERON:0001626 | 98.91 | gold quality |
| right ovary | UBERON:0002118 | 98.88 | gold quality |
| stromal cell of endometrium | CL:0002255 | 98.87 | gold quality |
| oocyte | CL:0000023 | 98.86 | gold quality |
| adrenal cortex | UBERON:0001235 | 98.78 | gold quality |
| ascending aorta | UBERON:0001496 | 98.77 | gold quality |
| thoracic aorta | UBERON:0001515 | 98.77 | gold quality |
| upper lobe of lung | UBERON:0008948 | 98.76 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 98.72 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 98.67 | gold quality |
| endocervix | UBERON:0000458 | 98.65 | gold quality |
| aorta | UBERON:0000947 | 98.65 | gold quality |
| omental fat pad | UBERON:0010414 | 98.63 | gold quality |
| peritoneum | UBERON:0002358 | 98.62 | gold quality |
| tibial artery | UBERON:0007610 | 98.61 | gold quality |
| popliteal artery | UBERON:0002250 | 98.60 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 98.58 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 98.57 | gold quality |
| pericardium | UBERON:0002407 | 98.55 | gold quality |
| lower esophagus | UBERON:0013473 | 98.54 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 98.54 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 98.54 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 98.53 | gold quality |
| minor salivary gland | UBERON:0001830 | 98.44 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 98.36 | gold quality |
| adenohypophysis | UBERON:0002196 | 98.32 | gold quality |
| embryo | UBERON:0000922 | 98.31 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 98.29 | gold quality |
| esophagus | UBERON:0001043 | 98.28 | gold quality |
| secondary oocyte | CL:0000655 | 98.18 | gold quality |
| mucosa of stomach | UBERON:0001199 | 98.17 | gold quality |
| coronary artery | UBERON:0001621 | 98.09 | gold quality |
| esophagus mucosa | UBERON:0002469 | 98.06 | gold quality |
| right atrium auricular region | UBERON:0006631 | 97.94 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 97.78 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 97.77 | gold quality |
| rectum | UBERON:0001052 | 97.74 | gold quality |
| thyroid gland | UBERON:0002046 | 97.71 | gold quality |
| amygdala | UBERON:0001876 | 97.67 | gold quality |
| seminal vesicle | UBERON:0000998 | 97.64 | gold quality |
| spinal cord | UBERON:0002240 | 97.55 | gold quality |
| body of stomach | UBERON:0001161 | 97.53 | gold quality |
| transverse colon | UBERON:0001157 | 97.49 | gold quality |
| sigmoid colon | UBERON:0001159 | 97.47 | gold quality |
| cortical plate | UBERON:0005343 | 97.39 | gold quality |
| caudate nucleus | UBERON:0001873 | 97.33 | gold quality |
| cardiac atrium | UBERON:0002081 | 97.31 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 97.27 | gold quality |
| adipose tissue | UBERON:0001013 | 97.19 | gold quality |
| islet of Langerhans | UBERON:0000006 | 97.11 | gold quality |
| nucleus accumbens | UBERON:0001882 | 97.08 | gold quality |
| body of pancreas | UBERON:0001150 | 97.07 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 97.04 | gold quality |
| small intestine | UBERON:0002108 | 97.04 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 97.00 | gold quality |
| right frontal lobe | UBERON:0002810 | 97.00 | gold quality |
| myometrium | UBERON:0001296 | 96.96 | gold quality |
| hypothalamus | UBERON:0001898 | 96.96 | gold quality |
| right uterine tube | UBERON:0001302 | 96.92 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 96.83 | gold quality |
| duodenum | UBERON:0002114 | 96.82 | gold quality |
| cingulate cortex | UBERON:0003027 | 96.82 | gold quality |
| colon | UBERON:0001155 | 96.80 | gold quality |
| stomach | UBERON:0000945 | 96.75 | gold quality |
| cartilage tissue | UBERON:0002418 | 96.73 | gold quality |
| putamen | UBERON:0001874 | 96.68 | gold quality |
| vena cava | UBERON:0004087 | 96.65 | gold quality |
| cauda epididymis | UBERON:0004360 | 96.65 | gold quality |
| pituitary gland | UBERON:0000007 | 96.64 | gold quality |
| intestine | UBERON:0000160 | 96.64 | gold quality |
| connective tissue | UBERON:0002384 | 96.54 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 96.51 | gold quality |
| pancreas | UBERON:0001264 | 96.46 | gold quality |
| large intestine | UBERON:0000059 | 96.45 | gold quality |
| right lobe of liver | UBERON:0001114 | 96.45 | gold quality |
| lung | UBERON:0002048 | 96.45 | gold quality |
| skin of leg | UBERON:0001511 | 96.41 | gold quality |
| mouth mucosa | UBERON:0003729 | 96.40 | gold quality |
| corpus callosum | UBERON:0002336 | 96.35 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 96.30 | gold quality |
Single-cell (SCXA)
Detected in 35 experiment(s), a significant marker in 30.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-180759 | yes | 1749.93 |
| E-GEOD-84465 | yes | 1516.07 |
| E-MTAB-9154 | yes | 1367.08 |
| E-MTAB-8142 | yes | 1333.38 |
| E-MTAB-9435 | yes | 1308.70 |
| E-MTAB-11121 | yes | 1000.38 |
| E-HCAD-10 | yes | 907.43 |
| E-HCAD-1 | yes | 78.42 |
| E-MTAB-6701 | yes | 64.60 |
| E-MTAB-8410 | yes | 56.77 |
| E-MTAB-10553 | yes | 51.91 |
| E-HCAD-5 | yes | 37.25 |
| E-HCAD-11 | yes | 35.91 |
| E-MTAB-7316 | yes | 33.09 |
| E-GEOD-137537 | yes | 32.32 |
HPA expression
RNA tissue specificity: Low tissue specificity
showing 60 of 78 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Spinal cord | tissue | 407.8 | |
| Medulla oblongata | tissue | 294.9 | |
| Corpus callosum | tissue | 291.8 | |
| Midbrain | tissue | 290.0 | |
| Substantia nigra | tissue | 286.2 | |
| Olfactory bulb | tissue | 283.9 | |
| Periaqueductal gray | tissue | 268.4 | |
| Placenta | tissue | 240.5 | medium |
| Hypothalamus | tissue | 230.7 | |
| Thalamus | tissue | 229.7 | |
| Pons | tissue | 227.0 | |
| Hippocampal formation | tissue | 225.4 | |
| Superior colliculi | tissue | 213.1 | |
| Adrenal gland | tissue | 202.8 | medium |
| Amygdala | tissue | 192.1 | |
| Endometrium 1 | tissue | 191.9 | medium |
| Septum | tissue | 184.1 | |
| Smooth muscle | tissue | 183.0 | medium |
| Kidney | tissue | 180.9 | medium |
| Vagina | tissue | 175.3 | low |
| Ventral forebrain | tissue | 158.6 | |
| Basal ganglia | tissue | 158.3 | medium |
| Putamen | tissue | 154.3 | |
| Ovary | tissue | 152.6 | medium |
| Urinary bladder | tissue | 146.1 | medium |
| Hippocampus | tissue | 145.1 | medium |
| Gallbladder | tissue | 142.7 | medium |
| Entorhinal cortex | tissue | 142.4 | |
| Cerebral cortex | tissue | 140.7 | medium |
| Motor cortex | tissue | 140.7 | |
| Esophagus | tissue | 140.6 | low |
| Temporal cortex | tissue | 138.8 | |
| Adipose tissue | tissue | 138.7 | not detected |
| Choroid plexus | tissue | 138.3 | |
| Liver | tissue | 134.4 | low |
| Cervix | tissue | 134.2 | low |
| Prefrontal cortex | tissue | 132.8 | |
| Retrosplenial cortex | tissue | 132.2 | |
| Insular cortex | tissue | 128.2 | |
| Duodenum | tissue | 127.9 | high |
| Seminal vesicle | tissue | 125.9 | medium |
| Occipital cortex | tissue | 124.3 | |
| Somatosensory cortex | tissue | 120.8 | |
| Nucleus accumbens | tissue | 119.2 | |
| Retrosplenial and cingulate cortex | tissue | 117.7 | |
| Retina | tissue | 115.9 | |
| Locus coeruleus | tissue | 114.5 | |
| Lung | tissue | 111.6 | medium |
| Postcentral gyrus | tissue | 110.7 | |
| Pituitary gland | tissue | 105.8 | |
| Breast | tissue | 99.8 | medium |
| Prostate | tissue | 98.0 | medium |
| Small intestine | tissue | 94.2 | high |
| Cerebellum | tissue | 90.3 | medium |
| Spleen | tissue | 88.6 | low |
| Caudate putamen | tissue | 87.3 | |
| Heart muscle | tissue | 83.9 | low |
| Fallopian tube | tissue | 83.0 | medium |
| Thyroid gland | tissue | 82.4 | medium |
| Pancreas | tissue | 78.6 | low |
Brain sub-regions (HPA Brain Atlas): detected in 192; highest nTPM — Ventral spinal cord (407.8), Dorsal spinal cord (379.8), White matter (291.8), Area postrema (246.0), Supraoptic nucleus (231.0).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting CNN3 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
showing 30 of 64 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
| HSA-MIR-12133 | 99.92 | 71.82 | 2006 |
| HSA-MIR-613 | 99.91 | 71.50 | 1710 |
| HSA-MIR-1271-5P | 99.91 | 71.99 | 1972 |
| HSA-MIR-124-3P | 99.89 | 73.74 | 3043 |
| HSA-MIR-506-3P | 99.89 | 73.55 | 3057 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-383-3P | 99.85 | 65.84 | 1359 |
| HSA-MIR-4495 | 99.82 | 72.08 | 3080 |
| HSA-MIR-202-5P | 99.78 | 67.65 | 991 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-4255 | 99.72 | 67.70 | 1541 |
| HSA-MIR-7-5P | 99.67 | 70.53 | 1809 |
| HSA-MIR-5700 | 99.64 | 69.88 | 2280 |
Functional genomics
gnomAD constraint: pLI 0.999, LOEUF 0.43, missense Z 2.77 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000370206 — one region, missense o/e 0.66.
Literature-anchored findings (GeneRIF, showing 12)
- These results suggest a role of calponin 3 in the regulation of Bone morphogenetic proteins -dependent cellular responses. (PMID:17825283)
- Gene rearrangements of CNN3 is associated with mucosa-associated lymphoid tissue lymphoma. (PMID:18927281)
- Results indicate that CNN3 regulates actin cytoskeleton rearrangement which is required for the plasma membranes of trophoblasts to become fusion competent. (PMID:20861310)
- The mRNA and protein level of calponin-3 were increase expression in brain in patiens with epilepsy. (PMID:22119193)
- Participates in actin stress fiber remodeling (PMID:23545751)
- CNN3 as a new pro-invasive protein in trophoblast cells that is induced under low oxygen conditions. (PMID:25050546)
- overexpressed CNN3 during sonic vibration increases expression of glutamate receptors and promotes functional neural differentiation of human umbilical cords-mesenchymal stem cells. (PMID:26175098)
- These results reveal the importance of the MEKK1-calponin-3 signaling pathway to cell contractility. (PMID:27528401)
- Cnn3 depletion resulted in increased and uncoordinated contractility of stress fibers that often led to breakage of individual actomyosin bundles within the stress fiber network. (PMID:30518778)
- CNN3 acts as a potential oncogene in cervical cancer by affecting RPLP1 mRNA expression. (PMID:32051425)
- Calponin 3 is associated with poor prognosis and regulates proliferation and metastasis in osteosarcoma. (PMID:32667904)
- Calponin 3 Acts as a Potential Diagnostic and Prognostic Marker and Promotes Glioma Cell Proliferation, Migration, and Invasion. (PMID:35792226)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cnn3b | ENSDARG00000029856 |
| danio_rerio | cnn3a | ENSDARG00000099510 |
| mus_musculus | Cnn3 | ENSMUSG00000053931 |
| rattus_norvegicus | Cnn3 | ENSRNOG00000011559 |
| caenorhabditis_elegans | WBGENE00000778 | |
| caenorhabditis_elegans | cpn-3 | WBGENE00000779 |
| caenorhabditis_elegans | cpn-4 | WBGENE00000780 |
Paralogs (5): CNN2 (ENSG00000064666), CNN1 (ENSG00000130176), TAGLN3 (ENSG00000144834), TAGLN (ENSG00000149591), TAGLN2 (ENSG00000158710)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1919244) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 3 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| exencephaly | 1 |
| abnormal nervous system development | 1 |
| neonatal lethality, complete penetrance | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Macaca fascicularis | Q4R5J4 | 100.0% | Diamond |
| Pongo abelii | Q5RFN6 | 100.0% | Diamond |
| Sus scrofa | Q08092 | 99.7% | Diamond |
| Bos taurus | Q2HJ38 | 99.7% | Diamond |
| Ovis aries | Q7YRL2 | 99.7% | Diamond |
| Mustela putorius furo | Q9GK38 | 99.0% | Diamond |
| Gallus gallus | P26932 | 98.9% | Diamond |
| Meleagris gallopavo | P37803 | 98.9% | Diamond |
| Xenopus laevis | Q3KQW7 | 57.5% | Diamond |
| Drosophila melanogaster | P14318 | 51.7% | Diamond |
| Echinococcus granulosus | Q24799 | 51.1% | Diamond |
| Dictyostelium discoideum | Q55GV9 | 47.2% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| SLC44A3-AS1 | ncRNA | 101928079 |
| SLC44A3 | protein-coding | 126969 |
| CNN3-DT | ncRNA | 729970 |
| MIR378G | ncRNA | 100616321 |
| MIR12133 | ncRNA | 113219466 |
| F3 | protein-coding | 2152 |
| TLCD4-RWDD3 | protein-coding | 100527978 |
| ALG14-AS1 | ncRNA | 101928098 |
| RWDD3-DT | ncRNA | 101928118 |
| TLCD4 | protein-coding | 148534 |
| ALG14 | protein-coding | 199857 |
| RWDD3 | protein-coding | 25950 |
Protein
Protein identifiers
Calponin-3 — Q15417 (reviewed: Q15417)
Alternative names: Calponin, acidic isoform
All UniProt accessions (2): E9PDU6, Q15417
UniProt curated annotations — full annotation on UniProt →
Function. Thin filament-associated protein that is implicated in the regulation and modulation of smooth muscle contraction. It is capable of binding to actin, calmodulin and tropomyosin. The interaction of calponin with actin inhibits the actomyosin Mg-ATPase activity.
Tissue specificity. Expressed in both non-smooth muscle tissues as well as smooth muscle tissues.
Similarity. Belongs to the calponin family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q15417-1 | 1 | yes |
| Q15417-2 | 2 | |
| Q15417-3 | 3 |
RefSeq proteins (3): NP_001272984, NP_001272985, NP_001830* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000557 | Calponin_repeat | Repeat |
| IPR001715 | CH_dom | Domain |
| IPR001997 | Calponin/LIMCH1 | Family |
| IPR003096 | SM22_calponin | Family |
| IPR036872 | CH_dom_sf | Homologous_superfamily |
| IPR050606 | Calponin-like | Family |
Pfam: PF00307, PF00402
UniProt features (13 total): repeat 3, modified residue 3, splice variant 2, chain 1, domain 1, sequence conflict 1, region of interest 1, compositionally biased region 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q15417-F1 | 67.78 | 0.33 |
Human Protein Atlas
Protein class: Predicted intracellular proteins, Plasma proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): actin filaments; cytosol
Antibody reliability (HPA): IH enhanced · IF enhanced
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3)
| Type | Positions |
|---|---|
| N6-acetyllysine | 23 |
| N6-methyllysine | 158 |
| Phosphoserine | 323 |
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 332 (showing top):
MODULE_52, GOBP_EPITHELIUM_DEVELOPMENT, BOYLAN_MULTIPLE_MYELOMA_PCA1_DN, KAAB_FAILED_HEART_ATRIUM_DN, CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN, MAZ_Q6, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP, CTATGCA_MIR153, CHX10_01, LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN, GOBP_CELL_CELL_ADHESION, MODULE_118, WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN
GO Biological Process (4): actin filament organization (GO:0007015), epithelial cell differentiation (GO:0030855), actomyosin structure organization (GO:0031032), cell-cell adhesion (GO:0098609)
GO Molecular Function (5): calmodulin binding (GO:0005516), actin filament binding (GO:0051015), cadherin binding involved in cell-cell adhesion (GO:0098641), actin binding (GO:0003779), protein binding (GO:0005515)
GO Cellular Component (4): cytosol (GO:0005829), adherens junction (GO:0005912), focal adhesion (GO:0005925), actin cytoskeleton (GO:0015629)
GO top-level categories
18 GO namespaces:
| Category | Terms |
|---|---|
| actin cytoskeleton organization | 2 |
| supramolecular fiber organization | 1 |
| cell differentiation | 1 |
| epithelium development | 1 |
| cell adhesion | 1 |
| protein binding | 1 |
| actin binding | 1 |
| protein-containing complex binding | 1 |
| cadherin binding | 1 |
| cell-cell adhesion | 1 |
| cell-cell adhesion mediator activity | 1 |
| cytoskeletal protein binding | 1 |
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| cell-cell junction | 1 |
| cell-substrate junction | 1 |
| cytoskeleton | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 6 of 13 annotations. The rest are phylogenetic / computational / electronic (IEA).
6 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| epithelial cell differentiation | BP | expression pattern |
| actin cytoskeleton | CC | direct assay |
| adherens junction | CC | high-throughput assay |
| cytosol | CC | direct assay |
| focal adhesion | CC | high-throughput assay |
| cadherin binding involved in cell-cell adhesion | MF | high-throughput assay |
Protein interactions and networks
STRING
showing 17 of 1,725 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CNN3 | VCL | P18206 | 603 |
| CNN3 | CALML4 | Q96GE6 | 485 |
| CNN3 | DSTN | P18282 | 473 |
| CNN3 | CALML3 | P27482 | 472 |
| CNN3 | CALML5 | Q9NZT1 | 472 |
| CNN3 | CALM1 | P02593 | 471 |
| CNN3 | CALD1 | Q05682 | 447 |
| CNN3 | PDLIM4 | P50479 | 446 |
| CNN3 | CALML6 | Q8TD86 | 443 |
| CNN3 | SMTN | P53814 | 426 |
| CNN3 | MYH14 | Q7Z406 | 410 |
| CNN3 | TMOD3 | Q9NYL9 | 390 |
| CNN3 | DOCK7 | Q96N67 | 383 |
| CNN3 | RSPH1 | Q8WYR4 | 370 |
| CNN3 | CALB2 | P22676 | 370 |
| CNN3 | DST | Q03001 | 370 |
| CNN3 | MACF1 | Q9UPN3 | 370 |
IntAct
Human interaction partners of CNN3 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
4 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| CARM1 | physical association | 0.400 | 1 |
| CRMP1 | physical association | 0.400 | 1 |
| F2RL1 | physical association | 0.370 | 1 |
| ATE1 | association | 0.350 | 1 |
BioGRID (111 interactions; top human partners by supporting records): ACTB (Proximity Label-MS; 3 records), CNN2 (Affinity Capture-MS; 3 records), PARK2 (Affinity Capture-MS; 3 records), ACTC1 (Proximity Label-MS; 2 records), CARM1 (Affinity Capture-MS; 2 records), HSPA1A (Affinity Capture-MS; 2 records), KCNA3 (Proximity Label-MS; 2 records), MAPT (Proximity Label-MS; 2 records), PARP1 (Proximity Label-MS; 2 records), SNCA (Proximity Label-MS; 2 records), YAP1 (Proximity Label-MS; 2 records), ACTA1 (Cross-Linking-MS (XL-MS)), ACTA2 (Cross-Linking-MS (XL-MS)), ACTG2 (Cross-Linking-MS (XL-MS)), BAP1 (Affinity Capture-MS)
SIGNOR signaling
2 signaling interactions:
| A | Effect | B | Mechanism |
|---|---|---|---|
| BTK | “up-regulates quantity” | CNN3 | phosphorylation |
| FYN | “down-regulates activity” | CNN3 | phosphorylation |
Protein complexes (CORUM) (1)
Experimentally-characterized complexes this protein is a subunit of (★ = the complex contains a known drug target).
1 complexes by size:
| Complex | Subunits | Members |
|---|---|---|
| Emerin complex 1 | 8 | ACTB, CNN3, EMD, LMO7, MYH9, MYO1E, SIKE1, SPTAN1 |
Disease & clinical
Genetic variants
Variant evidence for CNN3: 33 ClinVar records (1 pathogenic / likely pathogenic); 3 GWAS associations. Per-variant detail is on Sugi Variant.
ClinVar
33 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 25 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
Showing all 1 pathogenic / likely-pathogenic ClinVar records, ranked by ClinVar review status (expert panel → multiple submitters → single submitter), then by number of submitting labs.
| Variant ID | HGVS | Classification | Review | Submitters |
|---|---|---|---|---|
| 1073069 | NC_000001.10:g.(?94458793)(95538454_?)del | Pathogenic | criteria provided, single submitter | 1 |
Per-variant reference — Sugi Variant
Explore CNN3’s pathogenic and likely-pathogenic variants individually — each with its ClinVar classification and conditions, applied ACMG criteria (ClinGen expert panel, where curated), the calibrated in-silico predictors (AlphaMissense, REVEL, SaProt, conservation), gnomAD frequency, and the predictor-disagreement QC signal — on Sugi Variant.
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 37 predictions of 533):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 1:94899369–94899370 | donor_loss | 1.0000 | 5 |
| 1:94899519–94899521 | acceptor_gain | 1.0000 | 2 |
| 1:94899526 | acceptor_gain | 1.0000 | |
| 1:94901667–94901668 | donor_loss | 1.0000 | 5 |
| 1:94901786–94901787 | acceptor_loss | 1.0000 | 6 |
| 1:94902119–94902120 | donor_loss | 1.0000 | 5 |
| 1:94902259 | acceptor_loss | 1.0000 | |
| 1:94903120–94903121 | donor_loss | 1.0000 | 5 |
| 1:94903189–94903190 | acceptor_loss | 1.0000 | 6 |
| 1:94903397 | donor_gain | 1.0000 |
AlphaMissense
1,236 missense substitutions predicted likely pathogenic (of 2,188 scored), across 254 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| M179 | 9 | 0.990 | 0.999 |
| M168 | 9 | 0.981 | 0.999 |
| M208 | 9 | 0.981 | 0.999 |
| M247 | 9 | 0.956 | 0.996 |
| M219 | 9 | 0.949 | 0.996 |
| M258 | 9 | 0.883 | 0.987 |
| D108 | 8 | 0.997 | 0.999 |
| F104 | 8 | 0.996 | 1.000 |
| N85 | 8 | 0.992 | 0.997 |
| N171 | 8 | 0.983 | 0.999 |
| F152 | 8 | 0.979 | 1.000 |
| F89 | 8 | 0.978 | 0.999 |
| D102 | 8 | 0.978 | 0.995 |
| D200 | 8 | 0.978 | 0.994 |
| N211 | 8 | 0.973 | 0.999 |
| N114 | 8 | 0.969 | 0.999 |
| F48 | 8 | 0.953 | 0.999 |
| D269 | 8 | 0.951 | 0.992 |
| D190 | 8 | 0.945 | 0.990 |
| F4 | 8 | 0.934 | 0.996 |
HPA cancer prognostics
RNA cancer specificity: Cancer enhanced (Glioblastoma Multiforme)
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
1 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Kidney Renal Clear Cell Carcinoma (TCGA) | favorable | 1.94e-08 |
Disease associations
OMIM: gene MIM:602374 | disease phenotypes:
GWAS associations
3 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST001840_3 | Stearic acid (18:0) levels | 2e-14 |
| GCST001838_1 | Palmitic acid (16:0) levels | 3e-11 |
| GCST008103_67 | Bipolar disorder | 1e-6 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
53 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects expression, decreases methylation, increases expression | 3 |
| Cyclosporine | decreases expression | 3 |
| Particulate Matter | increases methylation, decreases expression, increases abundance, affects cotreatment | 3 |
| bisphenol F | increases expression, affects cotreatment | 2 |
| bisphenol S | increases expression, affects cotreatment | 2 |
| Cadmium | increases abundance, increases palmitoylation, increases expression, decreases reaction | 2 |
| Cadmium Chloride | decreases reaction, increases abundance, increases palmitoylation, increases expression | 2 |
| trichostatin A | decreases expression | 1 |
| sulforaphane | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| 2-bromopalmitate | decreases reaction, increases abundance, increases palmitoylation | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| cupric oxide | increases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| 4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide | increases expression | 1 |
| candoxin | increases expression | 1 |
| bisphenol B | increases expression | 1 |
| pentabrominated diphenyl ether 100 | decreases expression | 1 |
| hexabrominated diphenyl ether 153 | decreases expression | 1 |
| MRK 003 | decreases expression | 1 |
| bisphenol AF | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Ethanol | decreases expression | 1 |
| Antimycin A | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Caffeine | increases phosphorylation | 1 |
| Carbamazepine | affects expression | 1 |
| Cisplatin | decreases expression, decreases reaction | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_C8FJ | HAP1 CNN3 (-) | Cancer cell line | Male |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.